Hendrik Peter Scholl insider trades
Open-market stock purchases and sales by Hendrik Peter Scholl, Chief Medical Officer at Belite BIO, Inc, from SEC Form 4 filings since Apr 21, 2026.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 18, 2026 | BLTE Belite BIO, Inc | Sold | $542K |
| Jun 18, 2026 | BLTE Belite BIO, Inc | Sold | $707K |
| Jun 18, 2026 | BLTE Belite BIO, Inc | Sold | $175K |
| Jun 18, 2026 | BLTE Belite BIO, Inc | Sold | $14.1K |
| Jun 16, 2026 | BLTE Belite BIO, Inc | Sold | $283K |
| Jun 16, 2026 | BLTE Belite BIO, Inc | Sold | $108K |
| Jun 16, 2026 | BLTE Belite BIO, Inc | Sold | $438K |
| Jun 16, 2026 | BLTE Belite BIO, Inc | Sold | $75.9K |
| Jun 16, 2026 | BLTE Belite BIO, Inc | Sold | $14.2K |
| Jun 16, 2026 | BLTE Belite BIO, Inc | Sold | $64K |
| Jun 16, 2026 | BLTE Belite BIO, Inc | Sold | $272K |
| Jun 16, 2026 | BLTE Belite BIO, Inc | Sold | $150K |
| Apr 21, 2026 | BLTE Belite BIO, Inc | Bought (not open market) | — |
Companies traded
- BLTE Belite BIO, Inc: 12 sales, last Jun 18, 2026
Get free alerts when Hendrik Peter Scholl files a new trade →